Menu
The first section of the workshop includes refreshing and didactic presentations that help attendees understand the science of regenerative healing and be able to explain it to patients. Attendees will be provided the most up-to-date research regarding the ideal PRP formulation. A summary of the PRP research will be presented so attendees will have a solid understanding regarding the use of PRP in orthopedic applications and how different PRP formulations affect different treatment sites. Workshop attendees will be taught which factors and cell ratios are crucial in selecting a PRP system to optimize clinical impact for patients.
A light lunch will be provided. During the lunch break, attendees are encouraged to mingle and visit with their colleagues. During this time, innovative ideas about best practices are shared.
The afternoon section includes individualized, hands-on teaching during which each attendee will be able to prepare a PRP solution and observe it being injected into a live patient. There will be opportunity for attendees to ask medical assistants, office managers, and real-time providers about best practices and see how a streamlined PRP practice can be run.
The workshop will conclude with a presentation and discussion on how best to implement PRP into clinical practice. This will include a brief presentation on topics such as pricing, coding/billing, informed consent, and marketing approaches to launch a successful PRP practice. The workshop will conclude with a recap/overview along with a question and answer period.
Special 2019 Promotion: up to 75% of the workshop tuition ($600) will be applied as a credit toward an initial 10-kit purchase made by workshop attendees.
Dr. Riggs has been using regenerative therapies in clinical practice for the past 6 years.
His clinic in Portland, Oregon was the first in the U.S. to use Tropocells PRP.
His practice averages over 50 PRP procedures a month. He knows what it takes to launch
a successful PRP practice and has outlined the steps required to get there.
FDA cleared 510(k) Class II medical device: Tropocells PRP is intended for the safe and rapid preparation of autologous platelet-rich plasma (PRP) from a small sample of blood at the patient point of care. The PRP is mixed with autograft or allograft bone prior to application to a bony defect for improving handling characteristics. 510(k) number: BK110035
